4XX7
Crystal structure of M2A mutant of human macrophage migration inhibitory factor
Summary for 4XX7
Entry DOI | 10.2210/pdb4xx7/pdb |
Related | 4GRN 4GRO 4P01 4P0H 4PKZ 4PLU 4TRF 4TRU 4XX8 5BS9 5BSC 5BSI |
Descriptor | Macrophage migration inhibitory factor, SULFATE ION, ISOPROPYL ALCOHOL, ... (5 entities in total) |
Functional Keywords | isomerase, surface, mutation |
Biological source | Homo sapiens (Human) |
Cellular location | Secreted: P14174 |
Total number of polymer chains | 3 |
Total formula weight | 37385.29 |
Authors | Pantouris, G.,Lolis, E. (deposition date: 2015-01-29, release date: 2015-09-30, Last modification date: 2023-09-27) |
Primary citation | Pantouris, G.,Syed, M.A.,Fan, C.,Rajasekaran, D.,Cho, T.Y.,Rosenberg, E.M.,Bucala, R.,Bhandari, V.,Lolis, E.J. An Analysis of MIF Structural Features that Control Functional Activation of CD74. Chem.Biol., 22:1197-1205, 2015 Cited by PubMed Abstract: For more than 15 years, the tautomerase active site of macrophage migration inhibitory factor (MIF) and its catalytic residue Pro1 have been being targeted for the development of therapeutics that block activation of its cell surface receptor, CD74. Neither the biological role of the MIF catalytic site nor the mechanistic details of CD74 activation are well understood. The inherently unstable structure of CD74 remains the biggest obstacle in structural studies with MIF for understanding the basis of CD74 activation. Using a novel approach, we elucidate the mechanistic details that control activation of CD74 by MIF surface residues and identify structural parameters of inhibitors that reduce CD74 biological activation. We also find that N-terminal mutants located deep in the catalytic site affect surface residues immediately outside the catalytic site, which are responsible for reduction of CD74 activation. PubMed: 26364929DOI: 10.1016/j.chembiol.2015.08.006 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.77 Å) |
Structure validation
Download full validation report